Navigation Links
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Date:7/15/2008

NDA or other Cephalon Oncology compounds; interpretation of clinical results, particularly with respect to the TREANDA clinical trials; manufacturing development and capabilities; market prospects for its products; sales and earnings guidance; and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
2. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
3. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
4. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
5. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
8. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
9. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014 Astellas has appointed James ... (IP) in the Americas. Kellerman will report directly to ... counsel at Astellas. In his new role, Kellerman will ... the business and manage the region,s intellectual property matters, ... "I am very pleased to welcome Jim to Astellas. ...
(Date:9/2/2014)... Sept. 2, 2014  Numotion is pleased to announce the ... of Directors. Mark is a 30-year retired ... positions across the organization and was a GE Company Officer ... Mark spent many years running business units within GE Healthcare, ... Healthcare Americas. "We are delighted to welcome ...
(Date:9/2/2014)... Texas , Sept. 2, 2014  On July ... notice to Congress that it is moving forward to ... down the minutes until laboratories throughout the U.S. will ... Although some medical laboratories may subscribe to ... the FDA to put guidelines in place, it,s widely ...
Breaking Medicine Technology:Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3
... Today, Siemens (NYSE: SI ) announces the appointment ... Officer (CMIO), of the Health Services (HS) Business Unit. One ... Health Information Exchange (IHIE), Marc recently served as the President ... Siemens, Marc will be responsible for clinical informatics activities and ...
... Minn., Feb. 21, 2011 Acuo Technologies®, a ... the medical imaging industry for archiving, collaboration and ... of the latest release of its market leading ... significant enterprise capabilities including cloud-enablement, workflow services, and ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release 2
(Date:9/2/2014)... 03, 2014 Recently, Top 10 ... companies and announced that JustHost ( http://www.justhost.com/track/seohosts ) ... webmasters. , “The hosting suppliers we recommend are ... competitors on hosting features, uptime and server speed ... Best SEO Hosting says. “We believe that BlueHost ...
(Date:9/2/2014)... The exciting information sessions and AMTC ... Carey Lewis and Bob Wiley. The team of ... have the desire to illuminate entertainment with the light ... be invited to join the Bridge Training Program ... Saturday, Sept. 6, Charlotte Convention Center, 501 South College ...
(Date:9/2/2014)... Washington, DC (PRWEB) September 02, 2014 TCG, ... named by Inc. 5000 as one of the fastest-growing companies ... the eighth time total. TCG was previously recognized in 2013, ... 2001. , TCG’s revenue has grown 86% from 2010 to ... of the fastest growing businesses in America - up 635 ...
(Date:9/2/2014)... 02, 2014 Friendship Village of ... “This creates a contemporary marketing presence and ... its parent organization, Friendship Senior Options,” said Stephen ... Options. “By changing the logo, we are making ... to seniors and their families.” , Friendship Village ...
(Date:9/2/2014)... September 02, 2014 Cloud Medical Doctor ... “Cloud Based” Medical Practice Business Operations solutions and Billing ... Digital Cyber Security solutions for all industries announced today ... the trading floor of the CME in Chicago by ... stated that we are very proud of the recognition ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3
... the recent economic downturn, natural health degree ... still experiencing a wellness boom, as holistic ... the Internet,s top natural health career site ... training, chiropractic, nutrition, Reiki and reflexology career ...
... Upsher-Smith announces the launch of www.prenexa.com , a web site ... with more plant-based DHA (docosahexaenoic acid) than any other prenatal vitamin. ... ... Upsher-Smith announces the launch of prenexa.com, a web site devoted to ...
... from the Dutch Health Insurance System model, according to an ... of the Journal of Health Politics, Policy and Law ... at The University of Texas School of Public Health at ... coverage in the Netherlands and its possible lessons for the ...
... prevention and treatment for people living with HIV/AIDS. , ... ... annual World AIDS Day , global health activists gathered for ... today that nearly 6,000 people from 163 countries signed a petition ...
... SAN FRANCISCO, Dec. 8 Quantros, a leading ... healthcare industry, today,announced that the Agency for Healthcare ... Quantros Patient Safety Center as a Patient Safety,Organization ... . The Quantros Patient Safety Center,is a new ...
... iron from the heart in beta-thalassemia patients with mild to severe ... a subgroup analysis of 341 patients with myelodysplastic syndromes (MDS), Exjade ... -These results are part of the largest prospective trial ... transfusion-dependent anemias , , EAST HANOVER, ...
Cached Medicine News:Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 2Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 3Health News:UT public health policy expert says US can learn from Dutch universal health-care coverage 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 3Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 4Health News:Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO) 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 3Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 4Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 5Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 6Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 7Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 8Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 9
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: